SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

Search

EssilorLuxottica SA

Suletud

SektorTervishoid

243.1 -0.29

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

242.9

Max

243.6

Põhinäitajad

By Trading Economics

Sissetulek

993M

Müük

13B

P/E

Sektori keskmine

47.432

39.857

Dividenditootlus

1.7

Kasumimarginaal

7.512

Töötajad

153,498

EBITDA

3.6B

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+9.78% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

1.70%

2.42%

Järgmine tulemuste avaldamine

28. juuli 2025

Turustatistika

By TradingEconomics

Turukapital

-8.8B

112B

Eelmine avamishind

243.39

Eelmine sulgemishind

243.1

Uudiste sentiment

By Acuity

37%

63%

119 / 376 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

EssilorLuxottica SA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

9. juuli 2025, 06:54 UTC

Omandamised, ülevõtmised, äriostud

Meta Bought Minority Stake in Ray-Ban Maker EssilorLuxottica, Bloomberg Says, Citing Sources

30. mai 2025, 06:42 UTC

Omandamised, ülevõtmised, äriostud

Ray-Ban Maker EssilorLuxottica to Buy Optegra in Medical AI Push

23. apr 2025, 18:17 UTC

Tulu

Ray-Ban Maker EssilorLuxottica Implements Measures to Weather U.S. Tariffs -- Update

23. apr 2025, 16:36 UTC

Tulu

Ray-Ban Maker EssilorLuxottica to Implement Measures to Mitigate U.S. Tariffs

11. juuli 2025, 10:36 UTC

Market Talk

Luxury Sector Unlikely to Report Positive Prints -- Market Talk

9. juuli 2025, 14:31 UTC

Omandamised, ülevõtmised, äriostud

Meta Has Surged on the Back of AI Software. Why Hardware Is the Next Play. -- Barrons.com

9. juuli 2025, 12:25 UTC

Omandamised, ülevõtmised, äriostud

Meta Wants to Reboot the Metaverse. Why AI Glasses Could Hold the Key. -- Barrons.com

9. juuli 2025, 07:21 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Meta's Reported EssilorLuxottica Investment Seen as Vote of Confidence -- Market Talk

2. juuli 2025, 15:08 UTC

Market Talk

Luxury Sector Should Report a Slowdown -- Market Talk

1. juuli 2025, 11:26 UTC

Market Talk

Luxury Sector Expected to Remain Subdued -- Market Talk

1. juuli 2025, 11:12 UTC

Market Talk

Luxury Industry Faces Deceleration as Tourism Slows -- Market Talk

30. juuni 2025, 12:07 UTC

Market Talk

EssilorLuxottica Expected to Report Growth Across All Regions -- Market Talk

5. juuni 2025, 06:04 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica Doesn't Release Financial Details

5. juuni 2025, 06:03 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica: Transaction Is Expected to Close by the End of June

5. juuni 2025, 06:03 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica: A-Look Operates Over 90 Stores Under A-Look, Seen and OWL Banners

5. juuni 2025, 06:02 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica: Deal Aimed Complementing Long-Standing Position in Malaysia

5. juuni 2025, 06:00 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica to Buy A-Look, Seen and OWL Retail Stores in Malaysia

30. mai 2025, 08:58 UTC

Kuumad aktsiad

Stocks to Watch Friday: Dell, Marvell, Gap, Ulta -- WSJ

30. mai 2025, 06:04 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica: Deal to Close in 2025 Pending Approvals, Customary Closing Conditions

30. mai 2025, 06:03 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica Doesn't Disclose Financial Details

30. mai 2025, 06:02 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica: Acquisition Is Part of Med-Tech Strategy

30. mai 2025, 06:01 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica to Buy Ophthalmology Platform Optegra Clinics

30. mai 2025, 06:00 UTC

Omandamised, ülevõtmised, äriostud

EssilorLuxottica to Buy Optegra Clinics

24. apr 2025, 09:58 UTC

Market Talk
Tulu

EssilorLuxottica's Main Challenge Is Trade Environment -- Market Talk

24. apr 2025, 09:35 UTC

Market Talk
Tulu

EssilorLuxottica's Results Show Resilience Given Macroeconomic Woes -- Market Talk

24. apr 2025, 08:11 UTC

Market Talk
Tulu

EssilorLuxottica Shows Resilience, But Market Might Turn Cautious -- Market Talk

3. apr 2025, 08:00 UTC

Market Talk

European Luxury Companies Fall After Tariffs; Profit Margins Expected to Shrink -- Market Talk

28. märts 2025, 08:57 UTC

Market Talk

EssilorLuxottica Should Be Able to Cope With U.S. Volatility -- Market Talk

13. veebr 2025, 11:05 UTC

Market Talk
Tulu

EssilorLuxottica Seems Poised to Ride the Technology Wave -- Market Talk

13. veebr 2025, 10:54 UTC

Market Talk
Tulu

EssilorLuxottica's Midterm Margin Target Seems Challenging -- Market Talk

Võrdlus sarnastega

Hinnamuutus

EssilorLuxottica SA Prognoos

Hinnasiht

By TipRanks

9.78% tõus

12 kuu keskmine prognoos

Keskmine 268.09 EUR  9.78%

Kõrge 300 EUR

Madal 240 EUR

Põhineb 12 Wall Streeti analüütiku instrumendi EssilorLuxottica SA 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

12 ratings

7

Osta

5

Hoia

0

Müü

Tehniline skoor

By Trading Central

243.3 / 250.9Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

No Evidence

Sentiment

By Acuity

119 / 376 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest EssilorLuxottica SA

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.